메뉴 건너뛰기




Volumn 49, Issue 8, 2013, Pages 343-353

Guidelines for the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis;Normativa sobre el diagnóstico y tratamiento de la fibrosis pulmonar idiopática

Author keywords

Diagnosis; Idiopathic pulmonary fibrosis; Treatment

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; FIBROSING ALVEOLITIS; INTERNATIONAL COOPERATION; LIFE EXPECTANCY; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; TREATMENT PLANNING; ADENOVIRUS INFECTION; ANTIFIBROTIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; CELL THERAPY; CELLS; COMBINATION CHEMOTHERAPY; COMORBIDITY; CRACKLE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DYSPNEA; ENVIRONMENTAL FACTOR; EPITHELIAL MESENCHYMAL TRANSITION; FIBROCYTE; FOLLOW UP; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; GENE; GENE THERAPY; GENETIC PREDISPOSITION; HEPATITIS C; HEREDITY; HERPES SIMPLEX; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RISK PATIENT; HISTOPATHOLOGY; HOME OXYGEN THERAPY; HUMAN; INCIDENCE; LUNG CARCINOMA; LUNG EMPHYSEMA; LUNG LAVAGE; LUNG TRANSPLANTATION; MONOTHERAPY; MORTALITY; MUC5B GENE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SYMPTOMATOLOGY; TERC GENE; TERT GENE; TRANSBRONCHIAL BIOPSY; TREATMENT INDICATION;

EID: 84881029904     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2013.06.003     Document Type: Article
Times cited : (74)

References (80)
  • 1
    • 0034133548 scopus 로고    scopus 로고
    • Idiopathic pulmonary fibrosis: Diagnosis and treatment; joint statement of the American Thoracic Society and the European Respiratory Society
    • American Thoracic Society
    • Idiopathic pulmonary fibrosis: Diagnosis and treatment; joint statement of the American Thoracic Society and the European Respiratory Society. Am J Respir Crit Care Med 2000, 161:646-664. American Thoracic Society.
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 646-664
  • 2
    • 79952717349 scopus 로고    scopus 로고
    • An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management
    • Raghu G., Collard H.R., Egan J.J., Martinez F.J., Behr J., Brown K.K., et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824.
    • (2011) Am J Respir Crit Care Med , vol.183 , pp. 788-824
    • Raghu, G.1    Collard, H.R.2    Egan, J.J.3    Martinez, F.J.4    Behr, J.5    Brown, K.K.6
  • 4
    • 33748305617 scopus 로고    scopus 로고
    • An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations
    • Schünemann H.J., Jaeschke R., Cook D.J., Bria W.F., El-Solh A.A., Ernst A., et al. An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006, 174:605-614.
    • (2006) Am J Respir Crit Care Med , vol.174 , pp. 605-614
    • Schünemann, H.J.1    Jaeschke, R.2    Cook, D.J.3    Bria, W.F.4    El-Solh, A.A.5    Ernst, A.6
  • 8
    • 84865832642 scopus 로고    scopus 로고
    • The genetics and environmental causes of pulmonary fibrosis
    • Mcneal K., Schwartz D.A. The genetics and environmental causes of pulmonary fibrosis. Proc Am Thorac Soc 2012, 9:120-125.
    • (2012) Proc Am Thorac Soc , vol.9 , pp. 120-125
    • Mcneal, K.1    Schwartz, D.A.2
  • 10
    • 43449105048 scopus 로고    scopus 로고
    • Occupational risks for idiopathic pulmonary fibrosis mortality in the United States
    • Pinheiro G.A., Antao V.C., Wood J.M., Wassell J.T. Occupational risks for idiopathic pulmonary fibrosis mortality in the United States. Int J Occup Environ Health 2008, 14:117-123.
    • (2008) Int J Occup Environ Health , vol.14 , pp. 117-123
    • Pinheiro, G.A.1    Antao, V.C.2    Wood, J.M.3    Wassell, J.T.4
  • 11
    • 33744908816 scopus 로고    scopus 로고
    • Is idiopathic pulmonary fibrosis an environmental disease?
    • Taskar V.S., Coultas D.B. Is idiopathic pulmonary fibrosis an environmental disease?. Proc Am Thorac Soc 2006, 3:293-298.
    • (2006) Proc Am Thorac Soc , vol.3 , pp. 293-298
    • Taskar, V.S.1    Coultas, D.B.2
  • 12
    • 84455201657 scopus 로고    scopus 로고
    • Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis
    • Lee J.S., Ryu J.H., Elicker B.M., Lydell C.P., Jones K.D., Wolters P.J., et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011, 184:1390-1394.
    • (2011) Am J Respir Crit Care Med , vol.184 , pp. 1390-1394
    • Lee, J.S.1    Ryu, J.H.2    Elicker, B.M.3    Lydell, C.P.4    Jones, K.D.5    Wolters, P.J.6
  • 13
    • 34248372493 scopus 로고    scopus 로고
    • Idiopathic interstitial pneumonia: Do community and academic physicians agree on diagnosis?
    • Flaherty K.R., Andrei A.C., King T.E., Raghu G., Colby T.V., Wells A., et al. Idiopathic interstitial pneumonia: Do community and academic physicians agree on diagnosis?. Am J Respir Crit Care Med 2007, 175:1054-1060.
    • (2007) Am J Respir Crit Care Med , vol.175 , pp. 1054-1060
    • Flaherty, K.R.1    Andrei, A.C.2    King, T.E.3    Raghu, G.4    Colby, T.V.5    Wells, A.6
  • 14
    • 33744916992 scopus 로고    scopus 로고
    • Classification and natural history of the idiopathic interstitial pneumonias
    • Kim D.S., Collard H.R., King T.E. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006, 3:285-292.
    • (2006) Proc Am Thorac Soc , vol.3 , pp. 285-292
    • Kim, D.S.1    Collard, H.R.2    King, T.E.3
  • 15
    • 43249084804 scopus 로고    scopus 로고
    • MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
    • 0623-0633
    • Rosas I.O., Richards T.J., Konishi K., Zhang Y., Gibson K., Lokshin A.E., et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008, 5:e93. 0623-0633.
    • (2008) PLoS Med , vol.5
    • Rosas, I.O.1    Richards, T.J.2    Konishi, K.3    Zhang, Y.4    Gibson, K.5    Lokshin, A.E.6
  • 16
    • 0036469096 scopus 로고    scopus 로고
    • Comparative study of KL-6, surfactant protein-A, surfactantprotein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases
    • Ohnishi H., Yokoyama A., Kondo K., Zhang Y., Gibson K., Lokshin S.F., et al. Comparative study of KL-6, surfactant protein-A, surfactantprotein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Resp Crit Care Med 2002, 165:378-381.
    • (2002) Am J Resp Crit Care Med , vol.165 , pp. 378-381
    • Ohnishi, H.1    Yokoyama, A.2    Kondo, K.3    Zhang, Y.4    Gibson, K.5    Lokshin, S.F.6
  • 17
    • 65249098301 scopus 로고    scopus 로고
    • Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis
    • Moeller A., Gilpin S.E., Ask K., Cox G., Cook D., Gauldie J., et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 2009, 179:588-594.
    • (2009) Am J Resp Crit Care Med , vol.179 , pp. 588-594
    • Moeller, A.1    Gilpin, S.E.2    Ask, K.3    Cox, G.4    Cook, D.5    Gauldie, J.6
  • 19
    • 33847664321 scopus 로고    scopus 로고
    • Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease
    • Leslie K.O., Gruden J.F., Parish J.M., Scholand M.B. Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 2007, 131:407-423.
    • (2007) Arch Pathol Lab Med , vol.131 , pp. 407-423
    • Leslie, K.O.1    Gruden, J.F.2    Parish, J.M.3    Scholand, M.B.4
  • 21
    • 0038037974 scopus 로고    scopus 로고
    • Radiation exposure at chest CT: A statement of the Fleischner Society
    • Mayo J.R., Aldrich J., Muller N.L. Radiation exposure at chest CT: A statement of the Fleischner Society. Radiology 2003, 228:15-21.
    • (2003) Radiology , vol.228 , pp. 15-21
    • Mayo, J.R.1    Aldrich, J.2    Muller, N.L.3
  • 24
    • 0021256105 scopus 로고
    • The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical index
    • Mahler D.A., Weinberg D.H., Wells C.K., Feinstein A.R. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical index. Chest 1984, 85:751-758.
    • (1984) Chest , vol.85 , pp. 751-758
    • Mahler, D.A.1    Weinberg, D.H.2    Wells, C.K.3    Feinstein, A.R.4
  • 25
    • 78349286777 scopus 로고    scopus 로고
    • A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
    • Nishiyama O., Taniguchi H., Konodoh Y., Kimura T., Kato K., Kataoka K., et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J 2010, 36:1067-1072.
    • (2010) Eur Respir J , vol.36 , pp. 1067-1072
    • Nishiyama, O.1    Taniguchi, H.2    Konodoh, Y.3    Kimura, T.4    Kato, K.5    Kataoka, K.6
  • 26
    • 0037383035 scopus 로고    scopus 로고
    • Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)
    • Birring S.S., Pruden B., Carr A.J., Singh S.J., Morgan M.D.L., Pavord I.D. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003, 58:339-343.
    • (2003) Thorax , vol.58 , pp. 339-343
    • Birring, S.S.1    Pruden, B.2    Carr, A.J.3    Singh, S.J.4    Morgan, M.D.L.5    Pavord, I.D.6
  • 27
    • 77957202563 scopus 로고    scopus 로고
    • Development and validity testing of an IPF-specific version of the St George's respiratory questionnaire
    • Yorke J., Jones P.W., Swigris J.J. Development and validity testing of an IPF-specific version of the St George's respiratory questionnaire. Thorax 2010, 65:921-926.
    • (2010) Thorax , vol.65 , pp. 921-926
    • Yorke, J.1    Jones, P.W.2    Swigris, J.J.3
  • 28
    • 79951844263 scopus 로고    scopus 로고
    • Clinical course and prediction of survival in idiopathic pulmonary fibrosis
    • Ley B., Collard H.R., King T.E. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011, 183:431-440.
    • (2011) Am J Respir Crit Care Med , vol.183 , pp. 431-440
    • Ley, B.1    Collard, H.R.2    King, T.E.3
  • 29
    • 84863490896 scopus 로고    scopus 로고
    • Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: A 3-year prospective study
    • Mura M., Porretta M.A., Bargagli E., Sergiacomi G., Zompatori M., Sverzellati N., et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: A 3-year prospective study. Eur Respir J 2012, 40:101-109.
    • (2012) Eur Respir J , vol.40 , pp. 101-109
    • Mura, M.1    Porretta, M.A.2    Bargagli, E.3    Sergiacomi, G.4    Zompatori, M.5    Sverzellati, N.6
  • 30
    • 79960426037 scopus 로고    scopus 로고
    • Long-term curse and prognosis of idiopathic pulmonary fibrosis in the new millennium
    • Nathan S.D., Shlobin O.A., Weir N. Long-term curse and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011, 140:21-229.
    • (2011) Chest , vol.140 , pp. 21-229
    • Nathan, S.D.1    Shlobin, O.A.2    Weir, N.3
  • 31
    • 84455168726 scopus 로고    scopus 로고
    • Forced vital capacity in patients with idiopathic pulmonary fibrosis: Test properties and minimal clinically important difference
    • Du Bois R.M., Weycker D., Albera C., Bradford W.Z., Costabel U., Kartashov A., et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: Test properties and minimal clinically important difference. Am J Respir Crit Care Med 2011, 184:1382-1389.
    • (2011) Am J Respir Crit Care Med , vol.184 , pp. 1382-1389
    • Du Bois, R.M.1    Weycker, D.2    Albera, C.3    Bradford, W.Z.4    Costabel, U.5    Kartashov, A.6
  • 32
    • 79960193484 scopus 로고    scopus 로고
    • Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
    • Schmidt S.L., Nambiar A.M., Tayab N., Sundaram B., Han M.K., Gross B.H., et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011, 38:176-183.
    • (2011) Eur Respir J , vol.38 , pp. 176-183
    • Schmidt, S.L.1    Nambiar, A.M.2    Tayab, N.3    Sundaram, B.4    Han, M.K.5    Gross, B.H.6
  • 33
    • 79955520497 scopus 로고    scopus 로고
    • Six-minute-walk test in idiopathic pulmonary fibrosis: Test validation and minimal clinically important difference
    • Du Bois R.M., Weycker D., Albera C., Bradford W.Z., Costabel U., Kastashou A., et al. Six-minute-walk test in idiopathic pulmonary fibrosis: Test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011, 183:1231-1237.
    • (2011) Am J Respir Crit Care Med , vol.183 , pp. 1231-1237
    • Du Bois, R.M.1    Weycker, D.2    Albera, C.3    Bradford, W.Z.4    Costabel, U.5    Kastashou, A.6
  • 36
    • 39849111240 scopus 로고    scopus 로고
    • Computed tomography findings in pathological usual interstitial pneumonia: Relationship to survival
    • Sumikawa H., Johkoh T., Colby T.V., Ichikado K., Suga M., Taniguchi H., et al. Computed tomography findings in pathological usual interstitial pneumonia: Relationship to survival. Am J Respir Crit Care Med 2008, 177:433-439.
    • (2008) Am J Respir Crit Care Med , vol.177 , pp. 433-439
    • Sumikawa, H.1    Johkoh, T.2    Colby, T.V.3    Ichikado, K.4    Suga, M.5    Taniguchi, H.6
  • 40
  • 41
    • 84863134839 scopus 로고    scopus 로고
    • Acute exacerbation of idiopathic pulmonary fibrosis
    • Kim D.S. Acute exacerbation of idiopathic pulmonary fibrosis. Clin Chest Med 2012, 33:59-68.
    • (2012) Clin Chest Med , vol.33 , pp. 59-68
    • Kim, D.S.1
  • 42
    • 84863438783 scopus 로고    scopus 로고
    • Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
    • Judge E.P., Fabre A., Adamali H.I., Egan J.J. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Eur Respir J 2012, 40:93-100.
    • (2012) Eur Respir J , vol.40 , pp. 93-100
    • Judge, E.P.1    Fabre, A.2    Adamali, H.I.3    Egan, J.J.4
  • 43
    • 84865588568 scopus 로고    scopus 로고
    • Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
    • Nathan S.D., Cottin V. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Eur Respir Monogr 2012, 57:148-160.
    • (2012) Eur Respir Monogr , vol.57 , pp. 148-160
    • Nathan, S.D.1    Cottin, V.2
  • 44
    • 33645118315 scopus 로고    scopus 로고
    • Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
    • Lettieri C.J., Nathan S.D., Barnett S.D., Ahmad S., Shorr A. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006, 3:746-752.
    • (2006) Chest , vol.3 , pp. 746-752
    • Lettieri, C.J.1    Nathan, S.D.2    Barnett, S.D.3    Ahmad, S.4    Shorr, A.5
  • 45
    • 70349673627 scopus 로고    scopus 로고
    • Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension
    • Corte T.J., Wort S.J., Gatzoulis M.A., Macdonald P., Hansell D.M., Wells A.U. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax 2009, 64:883-888.
    • (2009) Thorax , vol.64 , pp. 883-888
    • Corte, T.J.1    Wort, S.J.2    Gatzoulis, M.A.3    Macdonald, P.4    Hansell, D.M.5    Wells, A.U.6
  • 46
    • 84855471916 scopus 로고    scopus 로고
    • Combined pulmonary fibrosis and emphysema syndrome: A review
    • Jankowich M.D., Rounds S.I.S. Combined pulmonary fibrosis and emphysema syndrome: A review. Chest 2012, 141:222-231.
    • (2012) Chest , vol.141 , pp. 222-231
    • Jankowich, M.D.1    Rounds, S.I.S.2
  • 47
    • 84856743162 scopus 로고    scopus 로고
    • Silent gastro-esophageal reflux and microaspiration in IPF: Mounting evidence for anti-reflux therapy
    • Raghu G., Meyer K.C. Silent gastro-esophageal reflux and microaspiration in IPF: Mounting evidence for anti-reflux therapy. Eur Respir J 2012, 39:242-245.
    • (2012) Eur Respir J , vol.39 , pp. 242-245
    • Raghu, G.1    Meyer, K.C.2
  • 49
    • 68249127904 scopus 로고    scopus 로고
    • Cumulative incidence of and predictive factors for lung cancer in IPF
    • Ozawa Y., Suda T., Naito T., Enomoto N., Hashimoto D., Fujisawa T., et al. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology 2009, 14:723-728.
    • (2009) Respirology , vol.14 , pp. 723-728
    • Ozawa, Y.1    Suda, T.2    Naito, T.3    Enomoto, N.4    Hashimoto, D.5    Fujisawa, T.6
  • 50
    • 57149114526 scopus 로고    scopus 로고
    • The association between idiopathic pulmonary fibrosis and vascular disease: A population-based study
    • Hubbard R.B., Smith C., le Jeune I., Gribbin J., Fogarty A.W. The association between idiopathic pulmonary fibrosis and vascular disease: A population-based study. Am J Respir Crit Care Med 2008, 178:1257-1261.
    • (2008) Am J Respir Crit Care Med , vol.178 , pp. 1257-1261
    • Hubbard, R.B.1    Smith, C.2    le Jeune, I.3    Gribbin, J.4    Fogarty, A.W.5
  • 51
    • 80051795063 scopus 로고    scopus 로고
    • Comprehensive care of the patient with idiopathic pulmonary fibrosis
    • Lee J.S., McLaughlin S., Collard H.R. Comprehensive care of the patient with idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2011, 17:348-354.
    • (2011) Curr Opin Pulm Med , vol.17 , pp. 348-354
    • Lee, J.S.1    McLaughlin, S.2    Collard, H.R.3
  • 56
    • 84861394764 scopus 로고    scopus 로고
    • Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
    • Idiopathic Pulmonary Fibrosis Clinical Research Network
    • Raghu G., Anstrom K.J., King T.E., Lasky J.A., Martinez F.J. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012, 366:1968-1977. Idiopathic Pulmonary Fibrosis Clinical Research Network.
    • (2012) N Engl J Med , vol.366 , pp. 1968-1977
    • Raghu, G.1    Anstrom, K.J.2    King, T.E.3    Lasky, J.A.4    Martinez, F.J.5
  • 57
    • 84861840824 scopus 로고    scopus 로고
    • Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
    • Cottin V. Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes. Eur Respir Rev 2012, 21:161-167.
    • (2012) Eur Respir Rev , vol.21 , pp. 161-167
    • Cottin, V.1
  • 58
    • 79956341531 scopus 로고    scopus 로고
    • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials
    • Noble P.W., Albera C., Bradford W.Z., Costabel U., Glassberg M.K., Kardatzke D., et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials. Lancet 2011, 377:1760-1769.
    • (2011) Lancet , vol.377 , pp. 1760-1769
    • Noble, P.W.1    Albera, C.2    Bradford, W.Z.3    Costabel, U.4    Glassberg, M.K.5    Kardatzke, D.6
  • 60
    • 84867320020 scopus 로고    scopus 로고
    • Adverse events of pirfenidone for the treatment of pulmonary fibrosis: A meta-analysis of randomized controlled trials
    • Jiang C., Huang H., Liu J., Wang Y., Lu Z., Xu Z. Adverse events of pirfenidone for the treatment of pulmonary fibrosis: A meta-analysis of randomized controlled trials. PLoS One 2012, 7:e47024.
    • (2012) PLoS One , vol.7
    • Jiang, C.1    Huang, H.2    Liu, J.3    Wang, Y.4    Lu, Z.5    Xu, Z.6
  • 62
    • 84864872340 scopus 로고    scopus 로고
    • The big clinical trials in idiopathic pulmonary fibrosis
    • Luppi F., Spagnolo P., Cerri S., Richeldi L. The big clinical trials in idiopathic pulmonary fibrosis. Curr Opin Pulm 2012, 18:428-432.
    • (2012) Curr Opin Pulm , vol.18 , pp. 428-432
    • Luppi, F.1    Spagnolo, P.2    Cerri, S.3    Richeldi, L.4
  • 64
    • 76749146423 scopus 로고    scopus 로고
    • Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis
    • Mollica C., Paone G., Conti V., Ceccarelli D., Schmid G., Mattia P., et al. Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration 2010, 79:209-215.
    • (2010) Respiration , vol.79 , pp. 209-215
    • Mollica, C.1    Paone, G.2    Conti, V.3    Ceccarelli, D.4    Schmid, G.5    Mattia, P.6
  • 65
    • 0038383219 scopus 로고    scopus 로고
    • Resultados y características clínicas de los pacientes con fibrosis pulmonar e insuficiencia respiratoria ingresados en una Unidad de Cuidados Intensivos. Estudio de 20 casos
    • Molina-Molina M., Badia J.R., Marín-Arguedas A., Xaubet A., Santos M.J., Nicolás J.M., et al. Resultados y características clínicas de los pacientes con fibrosis pulmonar e insuficiencia respiratoria ingresados en una Unidad de Cuidados Intensivos. Estudio de 20 casos. Med Clin (Barc) 2003, 121:63-67.
    • (2003) Med Clin (Barc) , vol.121 , pp. 63-67
    • Molina-Molina, M.1    Badia, J.R.2    Marín-Arguedas, A.3    Xaubet, A.4    Santos, M.J.5    Nicolás, J.M.6
  • 66
    • 33947386257 scopus 로고    scopus 로고
    • Sildefanil improves walk distance in idiopathic pulmonary fibrosis
    • Collard H.R., Anstrom J.K., Schwarz M.I., Zisman D.A. Sildefanil improves walk distance in idiopathic pulmonary fibrosis. Chest 2007, 131:897-899.
    • (2007) Chest , vol.131 , pp. 897-899
    • Collard, H.R.1    Anstrom, J.K.2    Schwarz, M.I.3    Zisman, D.A.4
  • 67
    • 80051790295 scopus 로고    scopus 로고
    • Pulmonary hypertension in idiopathic pulmonary fibrosis: A review
    • Pitsiou G., Papakosta D., Bouros D. Pulmonary hypertension in idiopathic pulmonary fibrosis: A review. Respiration 2011, 82:294-304.
    • (2011) Respiration , vol.82 , pp. 294-304
    • Pitsiou, G.1    Papakosta, D.2    Bouros, D.3
  • 72
    • 80054736643 scopus 로고    scopus 로고
    • Lung transplant in idiopathic pulmonary fibrosis
    • George T.J., Arnaoutakis G.J., Shah A.S. Lung transplant in idiopathic pulmonary fibrosis. Arch Surg 2011, 146:1204-1209.
    • (2011) Arch Surg , vol.146 , pp. 1204-1209
    • George, T.J.1    Arnaoutakis, G.J.2    Shah, A.S.3
  • 73
    • 55049096769 scopus 로고    scopus 로고
    • Physical training for interstitial lung disease
    • Holland A.E., Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev 2008, 4:CD006322.
    • (2008) Cochrane Database Syst Rev , vol.4
    • Holland, A.E.1    Hill, C.2
  • 74
    • 84855867125 scopus 로고    scopus 로고
    • Predictors of benefit following pulmonary rehabilitation for interstitial lung disease
    • Holland A.E., Hill C.J., Glaspone I., Goh N., McDonald C.F. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med 2012, 106:429-435.
    • (2012) Respir Med , vol.106 , pp. 429-435
    • Holland, A.E.1    Hill, C.J.2    Glaspone, I.3    Goh, N.4    McDonald, C.F.5
  • 76
    • 84865825444 scopus 로고    scopus 로고
    • Stem cells and pulmonary fibrosis: Cause or cure?
    • McNulty K., Janes S.M. Stem cells and pulmonary fibrosis: Cause or cure?. Proc Am Thorac Soc 2012, 9:164-171.
    • (2012) Proc Am Thorac Soc , vol.9 , pp. 164-171
    • McNulty, K.1    Janes, S.M.2
  • 78
    • 15944379648 scopus 로고    scopus 로고
    • Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis
    • Allen S., Raut S., Woollard J., Vassallo M. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med 2005, 19:128-130.
    • (2005) Palliat Med , vol.19 , pp. 128-130
    • Allen, S.1    Raut, S.2    Woollard, J.3    Vassallo, M.4
  • 79
    • 84868327008 scopus 로고    scopus 로고
    • Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: A randomised trial
    • Horton M.R., Santoprieto V., Mathew L., Horton K.M., Polito A.J., Liw M.C., et al. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: A randomised trial. Ann Intern Med 2012, 157:398-406.
    • (2012) Ann Intern Med , vol.157 , pp. 398-406
    • Horton, M.R.1    Santoprieto, V.2    Mathew, L.3    Horton, K.M.4    Polito, A.J.5    Liw, M.C.6
  • 80
    • 79958268586 scopus 로고    scopus 로고
    • Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient
    • Egan J.J. Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient. Eur Respir Rev 2011, 20:114-117.
    • (2011) Eur Respir Rev , vol.20 , pp. 114-117
    • Egan, J.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.